Table 3.

Themes and quotes for the best and worst daily experience.

BestWorst
Understanding the concept of OMERACT filter 2.0Knowledge gap and challenges regarding OMERACT Filter 2.0
“Useful to review OMERACT process and policies in Filter 2.0 session”“Do not understand Filter 2.0”
“Intellectual challenge especially with Filter 2.0”
“Struggling with Filter 2.0 and how to incorporate into research”
“Executive members are involved in development on Filter 2.0”“Apart from the OMERACTers, F2.0 will be extremely complicated to use as opposed to basic TDF”
“Challenge in F2.0 SIG: the word parsimony did not translate to other countries”
Networking and Intellectual StimulationVoting Issues/challenges Questions
“Finding people who think the way I would like to think”“Questions to vote on were not given enough time”
“Conversations and interaction”“Difficulty trying to follow decision without the data”
“Spirit interactivity”“Uncomfortable feeling in voting process (1/3 of participants were in the room during voting)”
“Meet people interested in same field, OMERACT is effective work, good to see people interested in same thing”“Trying to vote on things you didn’t go to”
“Networking”
“Make new friends”Data presentation skills and challenges
“Networking face to face - cannot be duplicated virtually especially with people interested in outcomes”“…slides went too fast no time to digest info that was presented”
“Similar interests”“Too much information to digest”
“Slide availability is not there”
“Difficult to review pre-reading materials, too much”
Small Group DiscussionsSmall Group Discussions
“(liked) Small group discussion after presentation of data”“Data vs time to discuss it in one of the break-out sessions”
“liked discussions”“No data on the topic in one of the break-out sessions”
“discussions were very informative”“Rapporteurs and moderators did not move the topic along”
“Final goal of discussions are not always clear”
“…discussion in (one of the) breakouts seemed driven by clinical practice.
Struggled with how it works in Clinical Trial — what was the value added?”
Patient involvementPlenary Session
“Patient involvement in SIG (special interest group) sessions”“Plenary summaries were not very useful unless you were attendance at the SIG”
“Patient involvement (was nice)”“We need to have more votes in the final plenary”
“Why hear a report from all SIG’s when I already selected the ones I thought were interesting”
Learning the science and process of outcomes researchChallenges with OMERACT process
“Watching sausage get made—looking at how these outcomes get created”“Understanding the OMERACT process —feels like I have a long way to go”
“Feel like I have understanding of what is happening”“Clarity in process assumes an incredible degree of complexity”
“Process feels like it is getting clearer”
“Stimulating discussions”
Collegial environment
“Friendly people”
Physical environmentPhysical environment
“Food is good”“Weather was bad…”
“Location”
Learning new skills
“Learnt how to do an accurate thumb exam”
Utility of Newbie Session
“Chance to come to newbie session”
“Newbie session is very important and it should continue”
OtherOther
“Sense of egalitarianism”“Limited participation from countries in the East”
“Being able to talk about topic back to my institution and bring back to Brazil the methodology”“Lack of sleep”
“No Abbreviations/Jargon should be used in presentations and program”
  • OMERACT: Outcome Measures in Rheumatology; TDF: truth, discrimination, feasibility; SIG: special interest group; F2.0: OMERACT Filter 2.0.